Recent progress in our understanding of the pathogenesis of infantile hemangiomas

Lymphatic Research and Biology

Volumn 3, Issue 4, 2005, Pages 219-225

  Friedlander, Sheila Fallon ^a,b   Ritter, Matthew R ^a   Friedlander, Martin ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHOXYESTRADIOL; ALPHA INTERFERON; ESTROGEN RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; PROGESTERONE RECEPTOR; SOMATOMEDIN B; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CONGENITAL BLOOD VESSEL MALFORMATION; ENDOTHELIUM CELL; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; HEMANGIOMA; HUMAN; INFANT; INFANT DISEASE; MOLECULAR CLONING; MOLECULAR MECHANICS; NONHUMAN; PATHOGENESIS; PLACENTA; PREMATURITY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STEM CELL; TUMOR GROWTH;

FORECASTING; HEMANGIOMA; HUMANS; INFANT; INFANT, NEWBORN;

EID: 30944437208     PISSN: 15396851     EISSN: None     Source Type: Journal    
DOI: 10.1089/lrb.2005.3.219     Document Type: Article

References (31)

1. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982;69:412-422.
2. Amir J, Metzker A, Krikler R, Reisner SH. Strawberry hemangioma in preterm infants. Pediatr Dermatol 1986;3:331-332.
3. Sasaki GH, Pang CY, Wittliff JL. Pathogenesis and treatment of infant skin strawberry hemangiomas: clinical and in vitro studies of hormonal effects. Plast Reconstr Surg 1984;73:359-370.
4. Lui W, Zhang S, Hu T, Wei F, Gao Y, Cheng N. Sex hormone receptors of hemangiomas in children. Chin Med J (Engl) 1997;110:349-351.
5. Mooberry SL. New insights into 2-methoxyestradiol, a promising antiangiogenic and antitumor agent. Curr Opin Oncol 2003;15:425-430.
6. Ezekowitz RA, Mulliken JB, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 1992;326:1456-1463.
7. Ritter MR, Dorrell MI, Edmonds J, Friedlander SF, Friedlander M. Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysis. Proc Natl Acad Sci USA 2002;99:7455-7460.
8. Yu Y, Flint AF, Mulliken JB, Wu JK, Bischoff J. Endothelial progenitor cells in infantile hemangioma. Blood 2004;103:1373-1375.
9. Walter JW, North PE, Waner M, Mizeracki A, Blei F, Walker JW, Reinisch JF, Marchuk DA. Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma. Genes Chromosomes Cancer 2002;33:295-303.
10. Boye E, Yu Y, Paranya G, Mulliken JB, Olsen BR, Bischoff J. Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest 2001; 107:745-752.
11. Takahashi K, Mulliken JB, Kozakewich HP, Rogers RA, Folkman J, Ezekowitz RA. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 1994;93:2357-2364.
12. Bielenberg DR, Bucana CD, Sanchez R, Mulliken JB, Folkman J, Fidler IJ. Progressive growth of infantile cutaneous hemangiomas is directly correlated with hyperplasia and angiogenesis of adjacent epidermis and inversely correlated with expression of the endogenous angiogenesis inhibitor, IFN-beta. Int J Oncol 1999;14:401-408.
13. Yu Y, Varughese J, Brown LF, Mulliken JB, Bischoff J. Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells. Am J Pathol 2001;159:2271-2280.
14. Walter JW, Blei F, Anderson JL, Orlow SJ, Speer MC, Marchuk DA. Genetic mapping of a novel familial form of infantile hemangioma. Am J Med Genet 1999;82:77-83.
15. Yu Y, Wylie-Sears J, Boscolo E, Mulliken JB, Bischoff J. Genomic imprinting of IGF2 is maintained in infantile hemangioma despite its high level of expression. Mol Med 2005 Feb 1; [Epub ahead of print].
16. Schneider DT, Schuster AE, Fritsch MK, Hu J, Olson T, Lauer S, Gobel U, Perlman EJ. Multipoint imprinting analysis indicates a common precursor cell for gonadal and nongonadal pediatric germ cell tumors. Cancer Res 2001;61:7268-7276.
17. North PE, Waner M, Mizeracki A, Mihm MC, Jr. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 2000; 31:11-22.
18. Dadras SS, North PE, Bertoncini J, Mihm MC, Detmar M. Infantile hemangiomas are arrested in an early developmental vascular differentiation state. Mod Pathol 2004;17:1068-1079.
19. Waner M, North PE, Scherer KA, Frieden IJ, Waner A, Mihm MC, Jr. The nonrandom distribution of facial hemangiomas. Arch Dermatol 2003;139:869-875.
20. Metry DW, Hawrot A, Altman C, Frieden IJ. Association of solitary, segmental hemangiomas of the skin with visceral hemangiomatosis. Arch Dermatol 2004; 140:591-596.
21. Tan ST, Wallis RA, He Y, Davis PF. Mast cells and hemangioma. Plast Reconstr Surg 2004;113:999-1011.
22. Hasan Q, Ruger BM, Tan ST, Gush J, Davis PF. Clusterin/apoJ expression during the development of hemangioma. Hum Pathol. 2000;31:691-697.
23. Ritter MR, Moreno SK, Dorrell MI, Rubens J, Ney J, Friedlander DF, Bergman J, Cunningham BB, Eichenfield L, Reinisch J, Cohen S, Veccione T, Holmes R, Friedlander SF, Friedlander M. Identifying potential regulators of infantile hemangioma progression through large-scale expression analysis: a possible role for the immune system and indoleamine 2,3 dioxygenase (IDO) during involution. Lymphat Res Biol 2003;1:291-299.
24. Tan ST, Hasan Q, Velickovic M, Ruger BM, Davis RP, Davis PF. A novel in vitro human model of hemangioma. Mod Pathol 2000;13:92-99.
25. Peng Q, Liu W, Tang Y, Yu S. The establishment of the hemangioma model in nude mouse. J Pediatr Surg 2005;40:1167-1172.
26. North PE, Waner M, Mizeracki A, Mrak RE, Nicholas R, Kincannon J, Suen JY, Mihm MC, Jr. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 2001;137: 559-570.
27. Burton BK, Schulz CJ, Angle B, Burd LI. An increased incidence of haemangiomas in infants born following chorionic villus sampling (CVS). Prenat Diagn 1995; 15:209-214.
28. Frieden IJ, Haggstrom AN, Drolet BA, Mancini AJ, Friedlander SF, Boon L, Chamlin SL, Baselga E, Garzon MC, Nopper AJ, Siegel DH, Mathes EW, Goddard DS, Bischoff J, North PE, Esterly NB. Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas. Pediatr Dermatol 2005;22:383-406.
29. Ritter MR, Reinisch J. Friedlander SF, Friedlander M. Myeloid cells in infantile hemangioma. Am J. Pathol 2006, in press.
30. North PE, DeAos I, Lal A, Riggins G, Marchuk DA, Waner M, Mihm MC. High expression of indoleamine 2,3 deoxygenase in infantile hemangioma: Evidence for immune tolerance. Mod Pathol 2004;17:97A.
31. North PE, Mizeracki A, Waner M, Davis P. Ex vivo hemangiogenesis in fibrin gels: A morphological and immunohistochemical analysis. Lab Invest 2003;83: 18A[abstract].